67 studies found for:    dermatomyositis
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy
Conditions: Polymyositis;   Dermatomyositis
Intervention: Other: Patients with polymyositis / dermatomyositis
2 Recruiting Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Conditions: Dermatomyositis;   Juvenile Dermatomyositis
Intervention: Drug: H.P. Acthar Gel
3 Completed Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis
Condition: Superficial Calcinosis
Interventions: Device: Fractional Carbon Dioxide (FCO2) Laser (Candela QuadraLase (TM));   Drug: Sodium thiosulfate
4 Completed Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention: Drug: Immunosuppressive Agents
5 Completed Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis
Condition: Dermatomyositis
Intervention: Drug: h5G1.1-mAb
6 Completed
Has Results
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
Conditions: Myositis;   Dermatomyositis;   Polymyositis;   Juvenile Dermatomyositis
Interventions: Drug: Rituximab;   Drug: Placebo
7 Active, not recruiting Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Adrenocorticotropic Hormone Gel
8 Completed Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)
Conditions: Polymyositis;   Dermatomyositis
Interventions: Drug: GB-0998;   Drug: Placebo of GB-0998
9 Completed Methimazole to Treat Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: methimazole
10 Recruiting Trial of IMO-8400 in Adult Patients With Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: IMO-8400 Dose Group 1;   Drug: IMO-8400 Dose Group 2;   Drug: Placebo
11 Recruiting Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Interventions: Drug: tocilizumab;   Drug: placebo
12 Completed Hand Function in Patients With Poly- or Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention:
13 Terminated Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: Prednisone;   Drug: Methotrexate;   Drug: Etanercept
14 Recruiting Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: JBT-101;   Drug: Placebo
15 Unknown  Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
Condition: Juvenile Dermatomyositis
Interventions: Drug: 3 MPDN pulse + PDN;   Drug: 3 MPDN pulse + PDN + CSA;   Drug: 3 MPDN pulse + PDN + MTX
16 Not yet recruiting Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)
Condition: Dermatomyositis
Interventions: Drug: Octagam 10%;   Other: Placebo
17 Completed
Has Results
A Pilot Study of Etanercept in Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: Etanercept;   Drug: Placebo
18 Recruiting Abatacept in Juvenile Dermatomyositis
Condition: Dermatomyositis
Intervention: Drug: Abatacept
19 Not yet recruiting Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis
Conditions: Dermatopolymyositis;   Interstitial Lung Disease
Intervention: Drug: Pirfenidone
20 Completed Safety and Efficacy of BAF312 in Dermatomyositis
Condition: Active Dermatomyositis
Interventions: Drug: BAF312 0.5 mg;   Drug: BAF312 2 mg;   Drug: BAF312 10 mg;   Drug: Placebo to BAF312

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years